Darcy PK - Search Results

1

Pharmacological and genetic strategies for targeting adenosine to enhance adoptive T cell therapy of cancer.

Sek K, Kats LM, Darcy PK, Beavis PA. Sek K, et al. Among authors: darcy pk. Curr Opin Pharmacol. 2020 Aug;53:91-97. doi: 10.1016/j.coph.2020.07.002. Epub 2020 Aug 24. Curr Opin Pharmacol. 2020. PMID: 32854024 Review.

2

Adoptive transfer of gene-engineered CD4+ helper T cells induces potent primary and secondary tumor rejection.

Moeller M, Haynes NM, Kershaw MH, Jackson JT, Teng MW, Street SE, Cerutti L, Jane SM, Trapani JA, Smyth MJ, Darcy PK. Moeller M, et al. Among authors: darcy pk. Blood. 2005 Nov 1;106(9):2995-3003. doi: 10.1182/blood-2004-12-4906. Epub 2005 Jul 19. Blood. 2005. PMID: 16030195 Free article.

3

Supernatural T cells: genetic modification of T cells for cancer therapy.

Kershaw MH, Teng MW, Smyth MJ, Darcy PK. Kershaw MH, et al. Among authors: darcy pk. Nat Rev Immunol. 2005 Dec;5(12):928-40. doi: 10.1038/nri1729. Nat Rev Immunol. 2005. PMID: 16322746 Review.

4

Adoptive transfer of chimeric FcepsilonRI gene-modified human T cells for cancer immunotherapy.

Teng MW, Kershaw MH, Jackson JT, Smyth MJ, Darcy PK. Teng MW, et al. Among authors: darcy pk. Hum Gene Ther. 2006 Nov;17(11):1134-43. doi: 10.1089/hum.2006.17.1134. Hum Gene Ther. 2006. PMID: 17052145

5

Antitumor activity of dual-specific T cells and influenza virus.

Murphy A, Westwood JA, Brown LE, Teng MW, Moeller M, Xu Y, Smyth MJ, Hwu P, Darcy PK, Kershaw MH. Murphy A, et al. Among authors: darcy pk. Cancer Gene Ther. 2007 May;14(5):499-508. doi: 10.1038/sj.cgt.7701034. Epub 2007 Mar 2. Cancer Gene Ther. 2007. PMID: 17332777

6

Adoptive transfer of gene-modified primary NK cells can specifically inhibit tumor progression in vivo.

Pegram HJ, Jackson JT, Smyth MJ, Kershaw MH, Darcy PK. Pegram HJ, et al. Among authors: darcy pk. J Immunol. 2008 Sep 1;181(5):3449-55. doi: 10.4049/jimmunol.181.5.3449. J Immunol. 2008. PMID: 18714017

7

Adoptive immunotherapy for cancer: the next generation of gene-engineered immune cells.

Berry LJ, Moeller M, Darcy PK. Berry LJ, et al. Among authors: darcy pk. Tissue Antigens. 2009 Oct;74(4):277-89. doi: 10.1111/j.1399-0039.2009.01336.x. Tissue Antigens. 2009. PMID: 19775368 Review.

8

Enhancing adoptive immunotherapy of cancer.

Westwood JA, Berry LJ, Wang LX, Duong CP, Pegram HJ, Darcy PK, Kershaw MH. Westwood JA, et al. Among authors: darcy pk. Expert Opin Biol Ther. 2010 Apr;10(4):531-45. doi: 10.1517/14712591003610622. Expert Opin Biol Ther. 2010. PMID: 20132063 Review.

9

Genetic modification of natural killer cells for adoptive cellular immunotherapy.

Pegram HJ, Kershaw MH, Darcy PK. Pegram HJ, et al. Among authors: darcy pk. Immunotherapy. 2009 Jul;1(4):623-30. doi: 10.2217/imt.09.36. Immunotherapy. 2009. PMID: 20635990 Review.

10

Enhancing the specificity of T-cell cultures for adoptive immunotherapy of cancer.

Duong CP, Westwood JA, Berry LJ, Darcy PK, Kershaw MH. Duong CP, et al. Among authors: darcy pk. Immunotherapy. 2011 Jan;3(1):33-48. doi: 10.2217/imt.10.81. Immunotherapy. 2011. PMID: 21174556

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

201 results

Search Page